Partnership will focus on essential new therapies across neurodegenerative diseases
News
Vygon and University hospital of Wales in heart patient partnership
Collaboration has created method for heart failure patients to receive at-home treatment
Positive data from LEO Pharma’s delgocitinib cream trial
Study involves the treatment of adults with moderate-to-severe chronic hand eczema
Bio&Bio’s toxic shock syndrome vaccine research concluded
Positive results showed the TSST-1 vaccine is effective with immunisation lasting for at least two years
Alvotech proposed biosimilar to Stelara accepted by EMA
The companies anticipate that the EMA could also recommend marketing authorisation for AVT04
Pharmacists to receive further mental health training
The pathway is a programme designed to develop pharmacists’ knowledge of mental health among patients
NICE fails to recommend Boehringer Ingelheim and Lilly Alliance’s empagliflozin
The treatment has been developed to treat certain chronic heart failure patients and is approved elsewhere
Vital funding established for Evonetix projects
Financing will allow company’s development of DNA synthesis chip technology to commercial scale
EU approves AstraZeneca Forxiga for use across the EU
Milestone therapy concerns the treatment of patients with symptomatic chronic heart failure
Kidney Cancer UK makes NICE plea
Charity highlights the need to find kidney cancer early and for better guidance among doctors
Alvotech and Advanz link-up for Xolair drive
Alvotech will be responsible for supply and Advanz will oversee commercialisation of biosimilar
PharmaTimes launches Clinical Researcher of the Year – the Americas 2023
PharmaTimes announces the launch of the 2023 event and hopes to see returning contestants from previous years as well as some new faces
Cambridge Cognition and Aardex collaborate to boost decentralised clinical trials
Partnership involves the study of real-time patient data and identification of adherence issues
Green light for AbbVie’s Crohn’s disease therapy Rinvoq
MHRA approval for Rinvoq which treats adults with moderate to severely active Crohn’s Disease
Endevica Bio and Orbit Discovery unite to boost cachexia therapeutics
The central focus of the agreement is to establish peptide hits from selected library populations
